Viridian Therapeutics Inc. (VRDN) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Viridian Therapeutics Inc...

NASDAQ: VRDN · Real-Time Price · USD
21.65
0.43 (2.03%)
At close: Oct 03, 2025, 3:59 PM
21.62
-0.14%
After-hours: Oct 03, 2025, 07:03 PM EDT

Viridian Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
99.59M 102.83M 155.58M 42.3M
Short-Term Investments
617.99M 374.54M 268.97M 154.67M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
501K 604K 7.61M 1.49M
Receivables
n/a 102K 102K 451K
Inventory
n/a n/a -6.62M n/a
Other Current Assets
20.88M 9.01M 6.52M n/a
Total Current Assets
738.46M 486.48M 424.55M 200.16M
Property-Plant & Equipment
3.44M 3.34M 2.94M 2.06M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
3.94M 3.95M 10.54M 3.55M
Total Assets
742.4M 490.42M 435.09M 203.71M
Account Payables
2.14M 2.24M 14.23M 2.33M
Deferred Revenue
288K 288K 288K 289K
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
45.44M 12.75M 4.87M 6.85M
Total Current Liabilities
47.87M 26.64M 33.35M 13.64M
Long-Term Debt
20.58M 20.2M 4.64M n/a
Other Long-Term Liabilities
2.02M 989K 1.17M 1.21M
Total Long-Term Liabilities
22.89M 21.77M 6.68M 2.36M
Total Liabilities
70.76M 48.4M 40.03M 15.99M
Total Debt
21.09M 21.05M 5.26M 520K
Book Value
671.64M 442.02M 395.06M 187.72M
Book Value Per Share
9.89 9.88 12.31 15.75
Common Stock
810K 540K 414K 239K
Retained Earnings
-995.86M -725.91M -488.17M -358.3M
Comprehensive Income
-10K 338K -390K -157K
Shareholders Equity
671.64M 442.02M 395.06M 187.72M
Total Investments
617.99M 374.54M 268.97M 154.67M